Increased polyamine intake inhibits age-associated alteration in global DNA methylation and 1,2-dimethylhydrazine-induced tumorigenesis.

by Kuniyasu Soda, Yoshihiko Kano, Fumihiro Chiba, Kei Koizumi, Yuichiro Miyaki
Published 2013-01-01

A difficult-to-diagnose fibromatosis-like metaplastic carcinoma of the breast: a case report

by Daiki Takatsuka, Hiroyuki Ogura, Yuko Asano, Akiko Nakamura, Kei Koizumi, Norihiko Shiiya, Satoshi Baba
Published 2021-01-01

Human breast cancer tissues contain abundant phosphatidylcholine(36∶1) with high stearoyl-CoA desaturase-1 expression.

by Yoshimi Ide, Michihiko Waki, Takahiro Hayasaka, Tomohisa Nishio, Yoshifumi Morita, Hiroki Tanaka, Takeshi Sasaki, Kei Koizumi, Ryoichi Matsunuma, Yuko Hosokawa, Hiroyuki Ogura, Norihiko Shiiya, Mitsutoshi Setou
Published 2013-01-01

Correction: Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) with High Stearoyl-CoA Desaturase-1 Expression

by Yoshimi Ide, Michihiko Waki, Takahiro Hayasaka, Tomohisa Nishio, Yoshifumi Morita, Hiroki Tanaka, Takeshi Sasaki, Kei Koizumi, Ryoichi Matsunuma, Yuko Hosokawa, Hiroyuki Ogura, Norihiko Shiiya, Mitsutoshi Setou
Published 2013-01-01

Correction: Human Breast Cancer Tissues Contain Abundant Phosphatidylcholine(36∶1) with High Stearoyl-CoA Desaturase-1 Expression.

by Yoshimi Ide, Michihiko Waki, Takahiro Hayasaka, Tomohisa Nishio, Yoshifumi Morita, Hiroki Tanaka, Takeshi Sasaki, Kei Koizumi, Ryoichi Matsunuma, Yuko Hosokawa, Hiroyuki Ogura, Norihiko Shiiya, Mitsutoshi Setou
Published 2013-01-01

Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advan...

by Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno
Published 2020-06-01

Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastat...

by Toshinari Yamashita, Norikazu Masuda, Shigehira Saji, Kazuhiro Araki, Yoshinori Ito, Toshimi Takano, Masato Takahashi, Junji Tsurutani, Kei Koizumi, Masahiro Kitada, Yasuyuki Kojima, Yasuaki Sagara, Hiroshi Tada, Tsutomu Iwasa, Takayuki Kadoya, Tsuguo Iwatani, Hiroki Hasegawa, Satoshi Morita, Shinji Ohno
Published 2020-05-01